Robert Young

3PUBLICATIONS
3CO-AUTHORS
Epidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 17, 2025
Relative Survival Modeling for Appraising the Cost-Effectiveness of Life-Extending Treatments: An Application to Tafamidis for the Treatment of Transthyretin Amyloidosis with Cardiomyopathy.

Robert Young, Jack Said, Sam Large

|Dec 06, 2024
Cost-Effectiveness of Nivolumab Plus Ipilimumab versus Chemotherapy for Previously Untreated Metastatic NSCLC Using Mixture-Cure Survival Analysis Based on CheckMate 227 5-Year Data.

Alison D Griffiths, Robert O Young, Yong Yuan

|Jun 18, 2021
Estimating the health benefits of timely diagnosis and treatment of transthyretin amyloid cardiomyopathy.

Mark H Rozenbaum, Samuel Large, Rahul Bhambri

Pageof 1

Frequent Collaborators

1 joint publications

Mark H Rozenbaum

1 joint publications

Alexander van Doornewaard

1 joint publications

Jack Said